Venus Lifescience Profile
Key Indicators
- Authorised Capital ₹ 8.50 M
as on 22-06-2024
- Paid Up Capital ₹ 7.09 M
as on 22-06-2024
- Company Age 18 Year, 9 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.00 M
as on 22-06-2024
- Revenue -37.60%
(FY 2020)
- Profit 137.71%
(FY 2020)
- Ebitda -440.51%
(FY 2020)
- Net Worth 24.07%
(FY 2020)
- Total Assets -37.34%
(FY 2020)
About Venus Lifescience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.50 M and a paid-up capital of Rs 7.09 M.
The company currently has active open charges totaling ₹8.00 M.
The Key Managerial Personnel (KMP) at Venus Lifescience Private Limited. India is Vinita Bhushan as CEO. Ravi Shankar, Vinita Bhushan, Ingita, and One other member serve as directors at the Company.
- CIN/LLPIN
U33119BR2006PTC012750
- Company No.
012750
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Dec 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Venus Lifescience Private Limited. offer?
Venus Lifescience Private Limited. offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, Nutraceuticals & Dietary Supplements, Mineral Supplement, Antibiotic Tablets & Capsules, Azithromycin Tablets, Vitamin Tablets & Capsules, Vitamin C Tablets & Capsules, Antifungal Injection, Tablet & Syrup, Itraconazole Capsule and Tablet.
Who are the key members and board of directors at Venus Lifescience?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vinita Bhushan | CEO | 21-Feb-2020 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rupesh Kumar  | Director | 17-Aug-2010 | Current |
| Ravi Shankar | Director | 02-Jan-2019 | Current |
| Vinita Bhushan | Director | 14-Dec-2006 | Current |
| Ingita | Director | 04-Jun-2008 | Current |
Financial Performance of Venus Lifescience.
Venus Lifescience Private Limited., for the financial year ended 2020, experienced significant reduction in revenue, with a 37.6% decrease. The company also saw a substantial improvement in profitability, with a 137.71% increase in profit. The company's net worth Soared by an impressive increase of 24.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Venus Lifescience?
In 2019, Venus Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kras Pharmaceuticals Private LimitedActive 39 years 2 monthsRavi Shankar, Vinita Bhushan and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Main Branch Patna Creation Date: 18 Feb 2010 | ₹8.00 M | Open |
How Many Employees Work at Venus Lifescience?
Unlock and access historical data on people associated with Venus Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Venus Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Venus Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
